Radiolabeled antibodies in cancer treatment.
The use of radiolabeled antibodies may play a major role in future treatment of cancer patients, affecting procedural operations throughout both radiology and radiation therapy departments. Because of the number of different radioisotopes that may be used, education of medical personnel will be of critical importance. Adaptation of current radiology procedures may enhance this therapeutic modality.